Last update 21 Dec 2024

ADM-03820

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
SARS-CoV-2 S protein
Mechanism
SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
COVID-19
Inactive Indication
Severe Acute Respiratory Syndrome
Originator Organization
Resilience Government Services, Inc.Resilience Government Services, Inc.
Active Organization
Resilience Government Services, Inc.Resilience Government Services, Inc.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with ADM-03820
NCT05142527 / WithdrawnPhase 2/3
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety, Tolerability, and Efficacy of ADM03820 to Prevent Symptomatic COVID-19 in Adult Subjects
NCT04592549 / CompletedPhase 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820 in Adults
100 Clinical Results associated with ADM-03820
Login to view more data
100 Translational Medicine associated with ADM-03820
Login to view more data
100 Patents (Medical) associated with ADM-03820
Login to view more data
100 Deals associated with ADM-03820
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 3-
Resilience Government Services, Inc.Resilience Government Services, Inc.
01 Jan 2023
Severe Acute Respiratory SyndromePhase 1
US
-19 Oct 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free